High-altitude global amnesia.

Area of Science:

• Neurology
• Altitude Medicine
• Physiology

Background:

• Transient neurological symptoms at high altitude are documented, often without acute mountain sickness.
• The specific phenomenon of transient global amnesia at high altitude requires further investigation.

Observation:

• A case series identified patients experiencing transient global amnesia while at high altitude.
• These episodes occurred without concurrent acute mountain sickness or other illnesses.

Findings:

• The condition is termed high-altitude global amnesia (HAGA).
• Pathophysiology suggests a link between hyperventilation, hypocapnic cerebral vasoconstriction, and localized brain hypoxia or ischemia.
• Individual variability in hypoxic ventilatory response and cerebral vasomotor reactivity are key factors.

Implications:

• Understanding HAGA is crucial for diagnosing and managing neurological events in high-altitude environments.
• This research highlights the potential impact of altered blood gas levels on cerebral function at altitude.
• Further studies are needed to confirm the proposed pathophysiology and explore preventative strategies.